Raymond James & Associates’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.37M | Sell |
|
|||||
|
2024
Q2 | $4.93M | Buy |
|
|||||
|
2024
Q1 | $3.28M | Sell |
|
|||||
|
2023
Q4 | $4.01M | Buy |
|
|||||
|
2023
Q3 | $3.36M | Buy |
|
|||||
|
2023
Q2 | $1.75M | Buy |
|
|||||
|
2023
Q1 | $687K | Buy |
|
|||||
|
2022
Q4 | $385K | Sell |
|
|||||
|
2022
Q3 | $1.49M | Buy |
|
|||||
|
2022
Q2 | $887K | Buy |
|
|||||
|
2022
Q1 | $266K | Sell |
|
|||||
|
2021
Q4 | $298K | Sell |
|
|||||
|
2021
Q3 | $396K | Buy |
|
|||||
|
2021
Q2 | $240K | Sell |
|
|||||
|
2021
Q1 | $671K | Buy |
|
|||||
|
2020
Q4 | $582K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $217K | Buy |
|